The A3S technology has been developed in order to eliminate any risks of bacterial and viral diseases spread through a pending patented biocidal effect treatment. We named this technology UmanProtek.
This technology is characterized by aluminum anodization and by a biocidal treatment to encapsulate inside of the nanopores. First of all, it should be known that anodization by electrolyte generates nanopores on an alumina ceramic layer. Then, a biocidal agent is used in those tiny pores. This agent is in charge of destroying infectious agents (A3S pending patented technology).